tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ANAB Stock Latest News

AnaptysBio price target raised to $54 from $52 at Guggenheim
The FlyAnaptysBio price target raised to $54 from $52 at Guggenheim
3d ago
ANAB
Hold Rating for AnaptysBio Amid Uncertainties in Clinical Trial Data and Market Position
PremiumRatings
Hold Rating for AnaptysBio Amid Uncertainties in Clinical Trial Data and Market Position
4d ago
ANAB
AnaptysBio reports Q1 EPS ($1.28), consensus ($1.46)
PremiumThe Fly
AnaptysBio reports Q1 EPS ($1.28), consensus ($1.46)
4d ago
ANAB
Promising Financial Future for AnaptysBio: Buy Rating Justified by Strategic Collaborations and Market Performance
PremiumRatings
Promising Financial Future for AnaptysBio: Buy Rating Justified by Strategic Collaborations and Market Performance
8d ago
ANAB
AnaptysBio could have positive read from J&J abstracts, says Guggenheim
PremiumThe Fly
AnaptysBio could have positive read from J&J abstracts, says Guggenheim
1M ago
JNJ
ANAB
AnaptysBio board authorizes $75M stock repurchase plan
PremiumThe FlyAnaptysBio board authorizes $75M stock repurchase plan
2M ago
ANAB
AnaptysBio sees cash runway through year-end 2027
Premium
The Fly
AnaptysBio sees cash runway through year-end 2027
2M ago
ANAB
Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
2M ago
ANAB
ANNX
AnaptysBio price target raised to $42 from $36 at JPMorgan
PremiumThe Fly
AnaptysBio price target raised to $42 from $36 at JPMorgan
2M ago
ANAB
Cautious Hold Rating on AnaptysBio Amid Mixed Clinical Trial Results and Strategic Uncertainties
PremiumRatings
Cautious Hold Rating on AnaptysBio Amid Mixed Clinical Trial Results and Strategic Uncertainties
2M ago
ANAB
AnaptysBio price target raised to $52 from $36 at Guggenheim
PremiumThe Fly
AnaptysBio price target raised to $52 from $36 at Guggenheim
2M ago
ANAB
AnaptysBio: Strong Financial Performance and Promising Pipeline Drive Buy Rating
PremiumRatings
AnaptysBio: Strong Financial Performance and Promising Pipeline Drive Buy Rating
2M ago
ANAB
Cautious Hold Rating on AnaptysBio Amid Uncertain Clinical Trial Outcomes and Strategic Decisions
PremiumRatingsCautious Hold Rating on AnaptysBio Amid Uncertain Clinical Trial Outcomes and Strategic Decisions
2M ago
ANAB
AnaptysBio Reports Strong Progress in Clinical Trials
Premium
Company Announcements
AnaptysBio Reports Strong Progress in Clinical Trials
2M ago
ANAB
AnaptysBio’s Promising Clinical Trials and Strong Financial Position Earn ‘Buy’ Rating from Analyst
Premium
Ratings
AnaptysBio’s Promising Clinical Trials and Strong Financial Position Earn ‘Buy’ Rating from Analyst
2M ago
ANAB
AnaptysBio reports Q4 EPS (72c), consensus ($1.70)
PremiumThe Fly
AnaptysBio reports Q4 EPS (72c), consensus ($1.70)
2M ago
ANAB
ANAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ANAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ANAB
AnaptysBio’s Promising Prospects Highlighted by Recent Data: A Buy Recommendation by David Risinger
PremiumRatings
AnaptysBio’s Promising Prospects Highlighted by Recent Data: A Buy Recommendation by David Risinger
3M ago
ANAB
Positive Outlook on AnaptysBio: Buy Rating Based on Undervaluation and Promising Pipeline
PremiumRatings
Positive Outlook on AnaptysBio: Buy Rating Based on Undervaluation and Promising Pipeline
3M ago
ANAB
AnaptysBio price target raised to $51 from $40 at Wells Fargo
PremiumThe FlyAnaptysBio price target raised to $51 from $40 at Wells Fargo
3M ago
ANAB
Positive Phase 2 Trial Results and Strong Safety Profile Boost Confidence in AnaptysBio’s Rosnilimab, Supporting Buy Rating and Increased Price Target
Premium
Ratings
Positive Phase 2 Trial Results and Strong Safety Profile Boost Confidence in AnaptysBio’s Rosnilimab, Supporting Buy Rating and Increased Price Target
3M ago
ANAB
AnaptysBio price target raised to $22 from $19 at H.C. Wainwright
Premium
The Fly
AnaptysBio price target raised to $22 from $19 at H.C. Wainwright
3M ago
ANAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >